These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21216936)

  • 21. Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression.
    Jonckheere N; Fauquette V; Stechly L; Saint-Laurent N; Aubert S; Susini C; Huet G; Porchet N; Van Seuningen I; Pigny P
    Br J Cancer; 2009 Aug; 101(4):637-44. PubMed ID: 19672266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.
    Onishi H; Morifuji Y; Kai M; Suyama K; Iwasaki H; Katano M
    Cancer Sci; 2012 Jul; 103(7):1272-9. PubMed ID: 22486854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y; Fan Y; Hu Y; Jing J; Wang C; Wu Y; Geng Q; Dong X; Li E; Dong D
    J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
    Zhang Z; Wang F; Du C; Guo H; Ma L; Liu X; Kornmann M; Tian X; Yang Y
    Cancer Lett; 2017 Aug; 402():213-224. PubMed ID: 28602977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.
    Lee J; Yakubov B; Ivan C; Jones DR; Caperell-Grant A; Fishel M; Cardenas H; Matei D
    Neoplasia; 2016 Nov; 18(11):689-698. PubMed ID: 27792935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
    Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP
    Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Guazzelli A; Meysami P; Bakker E; Demonacos C; Giordano A; Krstic-Demonacos M; Mutti L
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine.
    Gao CC; Xu XL; Li F; Gong BG; Liu S; Cui YQ; Sun HC; Xu PY; Zheng YM; Jiang H
    Tumour Biol; 2016 Jun; 37(6):7555-64. PubMed ID: 26684804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tubulin folding cofactor D is a microtubule destabilizing protein.
    Martín L; Fanarraga ML; Aloria K; Zabala JC
    FEBS Lett; 2000 Mar; 470(1):93-5. PubMed ID: 10722852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
    Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
    Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential role of tubulin-folding cofactor D in microtubule assembly and its association with microtubules in fission yeast.
    Hirata D; Masuda H; Eddison M; Toda T
    EMBO J; 1998 Feb; 17(3):658-66. PubMed ID: 9450991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability.
    Wu J; He Z; Wang DL; Sun FL
    Cell Cycle; 2016 Nov; 15(21):2980-2991. PubMed ID: 27715397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drosophila tubulin-binding cofactor B is required for microtubule network formation and for cell polarity.
    Baffet AD; Benoit B; Januschke J; Audo J; Gourhand V; Roth S; Guichet A
    Mol Biol Cell; 2012 Sep; 23(18):3591-601. PubMed ID: 22855530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
    Gan PP; McCarroll JA; Po'uha ST; Kamath K; Jordan MA; Kavallaris M
    Mol Cancer Ther; 2010 May; 9(5):1339-48. PubMed ID: 20442307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
    Liu J; Ma J; Wu Z; Li W; Zhang D; Han L; Wang F; Reindl KM; Wu E; Ma Q
    BMC Cancer; 2014 Sep; 14():686. PubMed ID: 25240403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cofactors B (TBCB) and E (TBCE) in tubulin heterodimer dissociation.
    Kortazar D; Fanarraga ML; Carranza G; Bellido J; Villegas JC; Avila J; Zabala JC
    Exp Cell Res; 2007 Feb; 313(3):425-36. PubMed ID: 17184771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHM-1, a novel microtubule-destabilizing agent exhibits antitumor activity via inducing the expression of SIRT2 in human breast cancer cells.
    Liu CW; Lin YC; Hung CM; Liu BL; Kuo SC; Ho CT; Way TD; Hung CH
    Chem Biol Interact; 2018 Jun; 289():98-108. PubMed ID: 29679549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Tubulin C354 mutations that severely decrease microtubule dynamics do not prevent nuclear migration in yeast.
    Gupta ML; Bode CJ; Thrower DA; Pearson CG; Suprenant KA; Bloom KS; Himes RH
    Mol Biol Cell; 2002 Aug; 13(8):2919-32. PubMed ID: 12181356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.